IL-6 production in response to purified mycobacterial heat-shock proteins and to antigen 85 in leprosy. 1993

P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
Institut Pasteur de Dakar, Service Immunologie, Sénégal.

IL-6 production was examined in PBMC cultures from healthy leprosy contacts and from leprosy patients stimulated with the purified mycobacterial 18-, 65-, and 70-kDa heat-shock proteins (hsp) and the secreted fibronectin-binding antigen 85 (Ag85). In lepromin-negative contacts, the 70-kDa hsp was the only antigen capable of eliciting significant IL-6 production. In lepromin-positive contacts, Ag85, the 65- and the 70-kDa hsp induced substantial IL-6 titers. IL-6 levels induced with the 70-kDa antigen were about fourfold higher than with the 65-kDa hsp or with Ag85. The 18-kDa antigen did not induce any IL-6 in these healthy contacts. PBMC from tuberculoid leprosy patients produced even more elevated levels of IL-6, and PBMC from lepromatous leprosy patients produced extremely high levels of IL-6. All antigens were capable of inducing IL-6 in leprosy patients. Highest levels were found in cultures stimulated with the 65-kDa hsp, and lowest levels were in cultures stimulated with the 18-kDa hsp.

UI MeSH Term Description Entries
D007916 Lepromin
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006360 Heat-Shock Proteins Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions. Stress Protein,Stress Proteins,Heat-Shock Protein,Heat Shock Protein,Heat Shock Proteins,Protein, Stress
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D015440 Leprosy, Lepromatous A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage. Leprosy, Cutaneous,Leprosy, Nodular,Cutaneous Leprosies,Cutaneous Leprosy,Lepromatous Leprosies,Lepromatous Leprosy,Leprosies, Cutaneous,Leprosies, Lepromatous,Leprosies, Nodular,Nodular Leprosies,Nodular Leprosy
D015441 Leprosy, Tuberculoid A principal or polar form of LEPROSY in which the skin lesions are few and are sharply demarcated. Peripheral nerve involvement is pronounced and may be severe. Unlike lepromatous leprosy (LEPROSY, LEPROMATOUS), the lepromin test is positive. Tuberculoid leprosy is rarely a source of infection to others. Leprosy, Macular,Leprosy, Neural,Tuberculoid Leprosy,Leprosies, Macular,Leprosies, Neural,Leprosies, Tuberculoid,Macular Leprosies,Macular Leprosy,Neural Leprosies,Neural Leprosy,Tuberculoid Leprosies
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
March 1994, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
January 1990, Autoimmunity,
P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
March 1992, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
January 1991, Indian journal of leprosy,
P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
July 1993, Fundamental and applied toxicology : official journal of the Society of Toxicology,
P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
March 2023, International journal of molecular sciences,
P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
June 2007, Current molecular medicine,
P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
November 1991, Clinical and experimental immunology,
P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
October 1991, European journal of immunology,
P Launois, and P Vandenbussche, and N N M'Bayame, and A Drowart, and J P Van Vooren, and J L Sarthou, and J Millan, and K Huygen
June 1999, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
Copied contents to your clipboard!